1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of RT1-CE5 mRNA CTD PMID:25380136 and PMID:30723492 17beta-estradiol increases expression ISO HLA-F (Homo sapiens) 6480464 Estradiol results in increased expression of HLA-F mRNA CTD PMID:19619570 and PMID:21185374 17beta-estradiol multiple interactions ISO HLA-F (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-F mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RT1-CE5 mRNA alternative form CTD PMID:20059583 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RT1-CE5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RT1-CE5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO HLA-F (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of HLA-F mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO HLA-F (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of HLA-F mRNA CTD PMID:19619570 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of RT1-CE5 mRNA CTD PMID:21346803 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of RT1-CE5 mRNA CTD PMID:25380136 5-fluorouracil increases expression ISO HLA-F (Homo sapiens) 6480464 Fluorouracil results in increased expression of HLA-F mRNA CTD PMID:16101138 acetamide increases expression EXP 6480464 acetamide results in increased expression of RT1-CE5 mRNA CTD PMID:31881176 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of RT1-CE5 mRNA CTD PMID:33354967 all-trans-retinoic acid increases expression ISO HLA-F (Homo sapiens) 6480464 Tretinoin results in increased expression of HLA-F mRNA CTD PMID:16054129 and PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of RT1-CE5 mRNA CTD PMID:16483693 amphotericin B increases expression ISO HLA-F (Homo sapiens) 6480464 Amphotericin B results in increased expression of HLA-F mRNA CTD PMID:20849824 antirheumatic drug decreases expression ISO HLA-F (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of HLA-F mRNA CTD PMID:24449571 arsenous acid decreases expression ISO HLA-F (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of HLA-F mRNA CTD PMID:15725085 and PMID:19128835 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of RT1-CE5 gene CTD PMID:28931070 benzo[a]pyrene increases methylation ISO HLA-F (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of HLA-F exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO HLA-F (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of HLA-F promoter CTD PMID:27901495 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HLA-C mRNA and bisphenol A affects the expression of RT1-CE5 mRNA CTD PMID:25181051 and PMID:30816183 bisphenol A multiple interactions ISO HLA-F (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of HLA-F gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RT1-CE5 mRNA CTD PMID:32145629 butanal increases expression ISO HLA-F (Homo sapiens) 6480464 butyraldehyde results in increased expression of HLA-F mRNA CTD PMID:26079696 cadmium atom increases expression ISO HLA-F (Homo sapiens) 6480464 Cadmium results in increased expression of HLA-F mRNA CTD PMID:24376830 carbon nanotube increases expression ISO HLA-F (Homo sapiens) 6480464 Nanotubes and Carbon results in increased expression of HLA-F mRNA CTD PMID:29906516 cefotaxime affects expression ISO HLA-F (Homo sapiens) 6480464 Cefotaxime affects the expression of HLA-F mRNA CTD PMID:25811541 cisplatin increases expression ISO HLA-F (Homo sapiens) 6480464 Cisplatin results in increased expression of HLA-F mRNA CTD PMID:20849824 cisplatin decreases expression ISO HLA-F (Homo sapiens) 6480464 Cisplatin results in decreased expression of HLA-F mRNA CTD PMID:27392435 copper atom multiple interactions ISO HLA-F (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of HLA-F mRNA CTD PMID:24690739 copper(0) multiple interactions ISO HLA-F (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of HLA-F mRNA CTD PMID:24690739 corn oil increases expression EXP 6480464 Corn Oil results in increased expression of RT1-CE5 mRNA CTD PMID:22760963 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of RT1-CE5 mRNA CTD PMID:26577399 and PMID:27523638 cyclophosphamide increases expression ISO HLA-F (Homo sapiens) 6480464 Cyclophosphamide results in increased expression of HLA-F mRNA CTD PMID:20849824 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of RT1-CE5 mRNA CTD PMID:23914054 diarsenic trioxide decreases expression ISO HLA-F (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of HLA-F mRNA CTD PMID:15725085 and PMID:19128835 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of RT1-CE5 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO HLA-F (Homo sapiens) 6480464 dicrotophos results in decreased expression of HLA-F mRNA CTD PMID:28302478 disulfiram multiple interactions ISO HLA-F (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of HLA-F mRNA CTD PMID:24690739 diuron decreases expression ISO HLA-F (Homo sapiens) 6480464 Diuron results in decreased expression of HLA-F mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO HLA-F (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HLA-F mRNA CTD PMID:27188386 elemental selenium increases expression ISO HLA-F (Homo sapiens) 6480464 Selenium results in increased expression of HLA-F mRNA CTD PMID:19244175 elemental selenium decreases expression ISO HLA-F (Homo sapiens) 6480464 Selenium results in decreased expression of HLA-F mRNA CTD PMID:19244175 entinostat increases expression ISO HLA-F (Homo sapiens) 6480464 entinostat results in increased expression of HLA-F mRNA CTD PMID:27188386 fulvestrant multiple interactions ISO HLA-F (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of HLA-F gene CTD PMID:31601247 gefitinib affects expression ISO HLA-F (Homo sapiens) 6480464 gefitinib affects the expression of HLA-F mRNA CTD PMID:25811541 gentamycin increases expression ISO HLA-F (Homo sapiens) 6480464 Gentamicins results in increased expression of HLA-F mRNA CTD PMID:20849824 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RT1-CE5 mRNA CTD PMID:33387578 hydrochlorothiazide affects expression ISO HLA-F (Homo sapiens) 6480464 Hydrochlorothiazide affects the expression of HLA-F mRNA CTD PMID:25811541 isotretinoin increases expression ISO HLA-F (Homo sapiens) 6480464 Isotretinoin results in increased expression of HLA-F mRNA CTD PMID:20436886 lidocaine decreases expression EXP 6480464 Lidocaine results in decreased expression of RT1-CE5 mRNA CTD PMID:35283115 lipopolysaccharide multiple interactions ISO HLA-F (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HLA-F mRNA CTD PMID:35811015 mifepristone multiple interactions ISO HLA-F (Homo sapiens) 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of HLA-F mRNA] CTD PMID:22490650 minocycline affects expression ISO HLA-F (Homo sapiens) 6480464 Minocycline affects the expression of HLA-F mRNA CTD PMID:25811541 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of RT1-CE5 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased methylation of RT1-CE5 promoter and [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RT1-CE5 mRNA CTD PMID:25374375 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of RT1-CE5 mRNA CTD PMID:25380136 nickel atom affects expression ISO HLA-F (Homo sapiens) 6480464 Nickel affects the expression of H2-T3 mRNA CTD PMID:14575637 nickel atom multiple interactions ISO HLA-F (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of H2-T3 mRNA] CTD PMID:14575637 nickel sulfate increases expression ISO HLA-F (Homo sapiens) 6480464 nickel sulfate results in increased expression of HLA-F mRNA CTD PMID:22714537 ochratoxin A increases expression ISO HLA-F (Homo sapiens) 6480464 ochratoxin A results in increased expression of HLA-F mRNA CTD PMID:29098329 ochratoxin A increases acetylation ISO HLA-F (Homo sapiens) 6480464 ochratoxin A results in increased acetylation of HLA-F promoter CTD PMID:29098329 ochratoxin A multiple interactions ISO HLA-F (Homo sapiens) 6480464 [ochratoxin A results in increased acetylation of HLA-F promoter] which results in increased expression of HLA-F mRNA CTD PMID:29098329 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RT1-CE5 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of RT1-CE5 mRNA CTD PMID:25729387 paracetamol decreases expression ISO HLA-F (Homo sapiens) 6480464 Acetaminophen results in decreased expression of HLA-F mRNA CTD PMID:22230336 pentanal increases expression ISO HLA-F (Homo sapiens) 6480464 pentanal results in increased expression of HLA-F mRNA CTD PMID:26079696 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased methylation of RT1-CE5 promoter and [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RT1-CE5 mRNA CTD PMID:25374375 pinostrobin increases expression ISO HLA-F (Homo sapiens) 6480464 pinostrobin results in increased expression of HLA-F mRNA CTD PMID:37777166 potassium chromate decreases expression ISO HLA-F (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of HLA-F mRNA CTD PMID:22714537 progesterone increases expression ISO HLA-F (Homo sapiens) 6480464 Progesterone results in increased expression of HLA-F mRNA CTD PMID:22490650 progesterone multiple interactions ISO HLA-F (Homo sapiens) 6480464 Mifepristone inhibits the reaction [Progesterone results in increased expression of HLA-F mRNA] CTD PMID:22490650 propanal increases expression ISO HLA-F (Homo sapiens) 6480464 propionaldehyde results in increased expression of HLA-F mRNA CTD PMID:26079696 Repaglinide affects expression ISO HLA-F (Homo sapiens) 6480464 repaglinide affects the expression of HLA-F mRNA CTD PMID:25811541 resveratrol increases expression ISO HLA-F (Homo sapiens) 6480464 resveratrol results in increased expression of HLA-F mRNA CTD PMID:17257620 resveratrol multiple interactions ISO HLA-F (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of HLA-F mRNA CTD PMID:23557933 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO HLA-F (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HLA-F mRNA CTD PMID:35811015 saquinavir affects expression ISO HLA-F (Homo sapiens) 6480464 Saquinavir affects the expression of HLA-F mRNA CTD PMID:25811541 SB 431542 multiple interactions ISO HLA-F (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HLA-F mRNA CTD PMID:27188386 selenium atom decreases expression ISO HLA-F (Homo sapiens) 6480464 Selenium results in decreased expression of HLA-F mRNA CTD PMID:19244175 selenium atom increases expression ISO HLA-F (Homo sapiens) 6480464 Selenium results in increased expression of HLA-F mRNA CTD PMID:19244175 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of RT1-CE5 mRNA CTD PMID:32721576 silicon dioxide increases expression ISO HLA-F (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of HLA-F mRNA CTD PMID:25351596 simvastatin affects expression ISO HLA-F (Homo sapiens) 6480464 Simvastatin affects the expression of HLA-F mRNA CTD PMID:25811541 sodium arsenite multiple interactions ISO HLA-F (Homo sapiens) 6480464 sodium arsenite results in decreased expression of and affects the splicing of HLA-F mRNA CTD PMID:25879800 sodium arsenite decreases expression ISO HLA-F (Homo sapiens) 6480464 sodium arsenite results in decreased expression of HLA-F mRNA CTD PMID:29301061 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of RT1-CE5 mRNA CTD PMID:25993096 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of RT1-CE5 mRNA CTD PMID:33387578 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RT1-CE5 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of RT1-CE5 mRNA CTD PMID:25729387 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of RT1-CE5 mRNA CTD PMID:21683754 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of RT1-CE5 mRNA CTD PMID:33387578 trichostatin A increases expression ISO HLA-F (Homo sapiens) 6480464 trichostatin A results in increased expression of HLA-F mRNA CTD PMID:27188386 trichostatin A multiple interactions ISO HLA-F (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of H2-T3 mRNA] CTD PMID:14575637 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of RT1-CE5 mRNA CTD PMID:30589522 valproic acid increases expression ISO HLA-F (Homo sapiens) 6480464 Valproic Acid results in increased expression of HLA-F mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO HLA-F (Homo sapiens) 6480464 Valproic Acid affects the expression of HLA-F mRNA CTD PMID:25979313 valproic acid multiple interactions ISO HLA-F (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HLA-F mRNA CTD PMID:27188386 vorinostat increases expression ISO HLA-F (Homo sapiens) 6480464 vorinostat results in increased expression of HLA-F mRNA CTD PMID:27188386 zoledronic acid increases expression ISO HLA-F (Homo sapiens) 6480464 zoledronic acid results in increased expression of HLA-F mRNA CTD PMID:24714768